RUBERTI, GIOVINA
 Distribuzione geografica
Continente #
AS - Asia 1.221
NA - Nord America 682
EU - Europa 263
SA - Sud America 231
AF - Africa 21
OC - Oceania 1
Totale 2.419
Nazione #
US - Stati Uniti d'America 655
SG - Singapore 541
CN - Cina 269
BR - Brasile 194
HK - Hong Kong 123
VN - Vietnam 105
IT - Italia 101
KR - Corea 69
DE - Germania 26
NL - Olanda 24
GB - Regno Unito 23
IN - India 23
FI - Finlandia 21
JP - Giappone 17
FR - Francia 16
AT - Austria 15
EC - Ecuador 12
AR - Argentina 11
IL - Israele 11
MX - Messico 10
BD - Bangladesh 8
IQ - Iraq 7
PL - Polonia 7
TR - Turchia 7
CA - Canada 6
ES - Italia 6
ID - Indonesia 6
IE - Irlanda 6
SE - Svezia 6
UZ - Uzbekistan 6
ZA - Sudafrica 6
CO - Colombia 5
PA - Panama 5
RU - Federazione Russa 5
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
UA - Ucraina 3
VE - Venezuela 3
AZ - Azerbaigian 2
BH - Bahrain 2
DZ - Algeria 2
JO - Giordania 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
SA - Arabia Saudita 2
SN - Senegal 2
TN - Tunisia 2
YT - Mayotte 2
AM - Armenia 1
BB - Barbados 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
MA - Marocco 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
SZ - Regno dello Swaziland 1
TH - Thailandia 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
UG - Uganda 1
UY - Uruguay 1
Totale 2.419
Città #
Singapore 324
Santa Clara 298
Hefei 128
Hong Kong 121
Rome 71
Seoul 68
Beijing 49
San Jose 39
Ashburn 37
Hanoi 32
Ho Chi Minh City 29
Los Angeles 28
Dallas 21
New York 21
Munich 12
São Paulo 11
Turku 11
Brooklyn 10
Minamishinagawa 8
Rio de Janeiro 8
Tokyo 8
Vienna 8
Denver 7
Düsseldorf 7
Ankara 6
London 6
Stockholm 6
Tashkent 6
Boston 5
Buffalo 5
Campinas 5
Chicago 5
Da Nang 5
Dublin 5
Haiphong 5
Helsinki 5
Quận Bình Thạnh 5
Quận Năm 5
Belo Horizonte 4
Bengaluru 4
Chennai 4
Curitiba 4
Guarulhos 4
Lappeenranta 4
Manchester 4
Medellín 4
Melito di Napoli 4
Orem 4
Salvador 4
Warsaw 4
Baghdad 3
Bauru 3
Brasília 3
Cape Town 3
Milan 3
Ninh Bình 3
Nuremberg 3
Osasco 3
Phoenix 3
Poplar 3
Quito 3
Ribeirão Preto 3
Suzano 3
Thái Bình 3
Vũng Tàu 3
Ahmedabad 2
Amman 2
Atlanta 2
Bady Bassitt 2
Baku 2
Bari 2
Betim 2
Biên Hòa 2
Bến Tre 2
Campo Novo do Parecis 2
Caracas 2
Catanduva 2
Colombo 2
Concepción 2
Cotia 2
Currais Novos 2
Dakar 2
Dubai 2
Frankfurt am Main 2
Goiânia 2
Guayaquil 2
Honolulu 2
Houston 2
Hải Dương 2
Jequié 2
Jinan 2
Johannesburg 2
Joinville 2
Mamoudzou 2
Manama 2
Marigliano 2
Monterrey 2
Mumbai 2
Nairobi 2
Naples 2
Totale 1.593
Nome #
Drug effects on metabolic profiles of Schistosoma mansoni adult male parasites detected by 1H-NMR spectroscopy 90
MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells. 80
Integrated analysis of DNA copy number and gene expression data in Lung Cancer models of resistance to targeted therapy 66
Establishment and characterization of EGFR Tyrosine Kinase Inhibitor-resistant lung cancer cell lines 63
Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent Inhibitors 61
Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems. 60
Natural human polyreactive IgM induce apoptosis of lymphoid cell lines and human peripheral blood mononuclear cells. 54
GSE80344: Gene expression profiling of Erlotinib sensitive and resistant human non small cell lung cancer (NSCLC) cell lines 54
Discovery by organism based high-throughput screening of new multi-stage compounds affecting Schistosoma mansoni viability, egg formation and production. 54
Crystal structures of Schistosoma mansoni histone deacetylase 8 reveal a novel binding site for allosteric inhibitors 51
Co-Expression Network Analysis Unveiled lncRNA-mRNA Links Correlated to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance and/or Intermediate Epithelial-to-Mesenchymal Transition Phenotypes in a Human Non-Small Cell Lung Cancer Cellular Model System 50
Spiroindoline-Capped Selective HDAC6 Inhibitors: Design, Synthesis, Structural Analysis, and Biological Evaluation 49
Thiazinoquinones as New Promising Multistage Schistosomicidal Compounds Impacting Schistosoma mansoni and Egg Viability. 48
Chemical Investigation of the Indonesian Tunicate Polycarpa aurata and Evaluation of the Effects Against Schistosoma mansoni of the Novel Alkaloids Polyaurines A and B. 46
Effects of structurally distinct human HDAC6 and HDAC6/HDAC8 inhibitors against S. mansoni larval and adult worm stages 45
The activity of a PI3K ?-sparing inhibitor, MEN1611, in non-small cell lung cancer cells with constitutive activation of the PI3K/AKT/mTOR pathway. 45
Development and Validation of a Luminescence-based, Medium-Throughput Assay for Drug Screening in Schistosoma mansoni. 44
CASP4 gene silencing in epithelial cancer cells leads to impairment of cell migration, cell-matrix adhesion and tissue invasion. 42
In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid Cancer Cell Lines 42
Screening and phenotypical characterization of Schistosoma mansoni histone deacetylase 8 (SmHDAC8) inhibitors as multi-stage antischistosomal agents 41
DNp63-mediated regulation of hyaluronic acid metabolism and signaling supports HNSCC tumorigenesis. 41
Investigating the Antiparasitic Potential of the Marine Sesquiterpene Avarone, Its Reduced form Avarol, and the Novel Semisynthetic Thiazinoquinone Analogue Thiazoavarone 40
Identification of novel multi-stage histone deacetylase (HDAC) inhibitors that impair Schistosoma mansoni viability and egg production 39
(+)-(R)- and (-)-(S)-Perhexiline maleate: Enantioselective synthesis and functional studies on Schistosoma mansoni larval and adult stages 39
Use of Perhexiline 38
Integrated analysis of DNA copy number and gene expression data in Lung cancer models of resistance to targeted therapy 38
Tis21-gene therapy inhibits medulloblastoma growth in a murine allograft model 38
Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability 38
IDDM12 Locus analysis in T1DM: identification and characterization of functional polymorphisms 38
Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigation 38
Characterization of epithelial-mesenchymal transition intermediate/hybrid phenotypes associated to resistance to EGFR inhibitors in non-small cell lung cancer cell lines 36
Co-ordinator report, JDRF-Telethon Project IDDM locus analysis in T1DM- Identification and characterization of functional polymorphisms , 2006-07 36
Luminescence-based, low- and medium-throughput assays for drug screening in schistosoma mansoni larval stage 33
Rendicontazione scientifica FBdQ_Laboratorio di Riferimento Farmaci innovativi - Modelli cellulari e murini II 32
Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway. 32
Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis 32
An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro. 32
N-Terminal and C-Terminal Domains of Calmodulin Mediate FADD and TRADD Interaction. 32
FADD-calmodulin interaction: A novel player in cell cycle regulation. 31
Comparative metabolic profiling by H-1-NMR spectroscopy analysis reveals the adaptation of S. mansoni from its host to in vitro culture conditions: a pilot study with ex vivo and GSH-supplemented medium-cultured parasites 29
Protection of CD95-mediated apoptosis by activation of phosphatidylinositide 3-kinase and protein kinase B. 25
Fas gene polymorphisms are not associated with systemic lupus erythematosus, multiple sclerosis and HIV infection 25
Fas and Fas ligand-mediated apoptosis and its role in autoimmune diabetes 24
Ricerca di molecole schistosomicide. Progetto "Creazione di un Centro per la ricerca di nuovi farmaci per malattie rare, trascurate e della povertà"-­- SP1-­-WP1 CNCCS-­-CNR_II Report 2014 24
CD95 ligand expression on alpha cells: protection or killing? 23
Ricerca di molecole schistosomicide. Progetto "Creazione di un Centro per la ricerca di nuovi farmaci per malattie rare, trascurate e della povertà"-­- SP1-­-WP1 CNCCS-­-CNR_I Report 2014 21
DETECTION OF POLYMORPHISMS WITHIN THE FAS CDNA GENE SEQUENCE BY GC-CLAMP DENATURING GRADIENT GEL-ELECTROPHORESIS 21
The 3' UTR of the human CTLA4 mRNA can regulate mRNA stability and translational efficiency. 21
Ricerca di molecole schistosomicide. Progetto "Creazione di un Centro per la ricerca di nuovi farmaci per malattie rare, trascurate e della povertà"-­- SP1-­-WP1 CNCCS-­-CNR_II Report 2013 21
Phenotypic and functional analysis of Fas (CD95) expression in primary central nervous system lymphoma of patients with acquired immunodeficiency syndrome 20
Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor 19
Co-ordinator report, CNR Ricerca a tema libero project, 2005 - FADD e TRADD nell'immunità naturale 19
Unit co-ordinator report, MIUR-CNR Project Genomica Funzionale-Funzioni di gruppo di geni a livello cellulare e di organismo- U.O. COMETA-COntrollo e Modulazione della Trasduzione del segnale apoptotico 19
ANALYSIS OF THE TERNARY COMPLEX OF ANTIGEN, MHC AND T-CELL RECEPTOR - THE INFLUENCE OF THE T-CELL RECEPTOR V-BETA REPERTOIRE ON THE V-BETA GENE ELEMENT USAGE 19
Co-ordinator report, Juvenile Diabets Research Foundation (JDRF), Innovative USA Grant - "Role of T1DM-associated CTLA-4 Polymorphisms on protein Trafficking and Compartmentalization" 18
CD95 and CD95-ligand expression in endocrine pancreas of NOD, NOR and BALB/c mice. 18
Rendicontazione scientifica FBdQ_Laboratorio di Riferimento Farmaci innovativi - Modelli cellulari e murini I anno 18
Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. 18
RESISTANCE TO GEMCITABINE IN A LYMPHOMA CELL LINE RESISTANT TO FAS-MEDIATED APOPTOSIS 18
SELECTION FOR AMINO-ACID-SEQUENCE AND J-BETA-ELEMENT USAGE IN THE BETA-CHAIN OF DBA 2V BETA(B)-DERIVED AND DBA 2V BETA(A)-DERIVED MYOGLOBIN-SPECIFIC T-CELL CLONES 18
The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis 17
Schistosomiasi malattia parassitaria negletta: identificazione di nuovi bersagli epigenetici_II Report 2014 17
Soluble Fas/Apo-1 splicing variants and apoptosis 17
Schistosomiasi malattia parassitaria negletta: identificazione di nuovi bersagli epigenetici. I Report 2014 17
Requirement for CD8+ cells in T cell receptor peptide-induced clonal unresponsiveness. 17
null 17
THE T-CELL RECEPTOR REPERTOIRE INFLUENCES V-BETA ELEMENT USAGE IN RESPONSE TO MYOGLOBIN 16
Reduced cumulative incidence of diabetes but not insulitis following administration of chimeric human IL-15-murine IgG2b in NOD mice 16
Multiple pathways originate at the Fas/APO-1 (CD95) receptor: sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. 15
MOLECULAR ANALYSIS OF THE ROLE OF THE HLA CLASS-II GENES DRB1, DQA1, DQB1, AND DPB1 IN SUSCEPTIBILITY TO LYME ARTHRITIS 15
The European Innovative Medicines Initiative 15
Rendicontazione scientifica FBdQ_Laboratorio di Riferimento Farmaci innovativi - Modelli cellulari e murini 15
Ricerca di molecole schistosomicide. Progetto "Creazione di un Centro per la ricerca di nuovi farmaci per malattie rare, trascurate e della povertà"-­- SP1-­-WP1 CNCCS-­-CNR_I Report 2013 15
Potential involvement of fas and its ligand in the pathogenesis of Hashimoto's thyroiditis 14
Ricerca di molecole schistosomicide. Progetto "Creazione di un Centro per la ricerca di nuovi farmaci per malattie rare, trascurate e della povertà"-­- SP1-­-WP1 CNCCS-­-CNR_II Report 2012 13
null 12
PRESENTATION OF ANTIGEN BY MIXED ISOTYPE CLASS-II MOLECULES IN NORMAL H-2D MICE 12
Totale 2.466
Categoria #
all - tutte 8.091
article - articoli 6.326
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 45
Totale 14.462


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202447 0 0 0 0 0 0 0 0 1 0 38 8
2024/20251.255 5 6 90 44 282 40 38 104 53 51 297 245
2025/20261.164 97 135 152 316 348 74 42 0 0 0 0 0
Totale 2.466